Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Teva
Farmers Insurance
Cipla
Healthtrust
McKinsey
Johnson and Johnson
QuintilesIMS
Novartis
Medtronic

Generated: January 22, 2018

DrugPatentWatch Database Preview

MOMETASONE FUROATE Drug Profile

« Back to Dashboard

When do Mometasone Furoate patents expire, and when can generic versions of Mometasone Furoate launch?

Mometasone Furoate is a drug marketed by Fougera Pharms, G And W Labs, Glenmark Generics, Taro, Tolmar, Perrigo Israel, Perrigo New York, Amneal Pharms, and Apotex Inc. and is included in nineteen NDAs.

The generic ingredient in MOMETASONE FUROATE is mometasone furoate. There are twenty-nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Drug patent expirations by year for MOMETASONE FUROATE
Pharmacology for MOMETASONE FUROATE
Medical Subject Heading (MeSH) Categories for MOMETASONE FUROATE

US Patents and Regulatory Information for MOMETASONE FUROATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms MOMETASONE FUROATE mometasone furoate CREAM;TOPICAL 076171-001 Apr 8, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms MOMETASONE FUROATE mometasone furoate SPRAY, METERED;NASAL 207989-001 Apr 3, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
G And W Labs MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 077678-001 Nov 21, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro MOMETASONE FUROATE mometasone furoate CREAM;TOPICAL 076679-001 Dec 21, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms MOMETASONE FUROATE mometasone furoate OINTMENT;TOPICAL 077061-001 Mar 28, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 090506-001 Aug 9, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc MOMETASONE FUROATE mometasone furoate SPRAY, METERED;NASAL 091161-001 Mar 22, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro MOMETASONE FUROATE mometasone furoate OINTMENT;TOPICAL 076624-001 Dec 3, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics MOMETASONE FUROATE mometasone furoate OINTMENT;TOPICAL 078571-001 May 28, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
G And W Labs MOMETASONE FUROATE mometasone furoate CREAM;TOPICAL 077447-001 May 22, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
Accenture
AstraZeneca
QuintilesIMS
Boehringer Ingelheim
Fuji
McKinsey
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot